Skip to main content

Nathalie D. Mckenzie, MD

Nathalie D. Mckenzie, MD

Gynecologic Oncologist

Cancer

Nathalie Mckenzie

Overview

Natalie Dauphin McKenzie, MD, MSPH, is a board-certified gynecologic oncologist with a breadth of experience providing advanced treatments including minimally invasive and robotic-assisted procedures for women with all types of gynecologic cancer. She earned her medical degree with research honors at the University of New York at Buffalo and undertook her residency training and fellowship at the University of Miami/Jackson Memorial Hospital. She also earned her Master of Science in Public Health with honors while completing her fellowship training.

Dr. McKenzie is an award-winning physician who is known for her expertise in radical debulking procedures for removing advanced tumors. She is particularly interested in HPV-related neoplasia and patient-driven cancer treatment. She is also a multilingual provider with fluency in English, French, medical Spanish and Haitian Creole.

Articles

Isolated vulvar Langerhans cell histiocytosis

GYNECOLOGIC ONCOLOGY REPORTS

2021

Carcinomatosis in Early-Stage Cervical Cancer Treated with Robotic Radical Hysterectomy: Recurrence Patterns, Risk Factors, and Survival

ANNALS OF SURGICAL ONCOLOGY

2021

ASO Visual Abstract: Carcinomatosis in Early-Stage Cervical Cancer Treated with Robotic Radical Hysterectomy-Recurrence Patterns, Risk Factors, and Survival

ANNALS OF SURGICAL ONCOLOGY

2021

The gut microbiome and cancer immunotherapeutics: A review of emerging data and implications for future gynecologic cancer research

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

2021

Neoadjuvant chemotherapy followed by fertility sparing surgery in cervical cancers size 2-4 cm; emerging data and future perspectives

GYNECOLOGIC ONCOLOGY

2021

Phase 1 trial of nelfinavir added to standard cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancer

CANCER

2021

Robotic sentinel lymph node (SLN) mapping in endometrial cancer: SLN symmetry and implications of mapping failure

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

2020

Phase II VIRO-15 trial of olvimulogene nanivacirepvec (Olvi-Vec)-primed immunochemotherapy in platinum-resistant/refractory ovarian cancer (PRROC) (NCT02759588)

GYNECOLOGIC ONCOLOGY

2020

The effect of intraperitoneal chemotherapy after interval cytoreductive surgery on recurrence and survival in patients with advanced-stage ovarian carcinoma

GYNECOLOGIC ONCOLOGY

2020

Phase II trial of oncolytic vaccinia virus primed immunochemotherapy in platinum-resistant/refractory ovarian cancer (PRROC) (NCT02759588)

ANNALS OF ONCOLOGY

2020

Education & Training

Education

University of New York at Buffalo School of Medicine, Buffalo, NY

Residency

Memorial Sloan Kettering Cancer Center, NY

Fellowship

University of Miami/ Jackson Memorial Hospital, Miami, FL

Specialty

Gynecology Oncology

Board Certifications

American Board of Obstetrics and Gynecology

Associated Clinical Trials